| Matz Family Chiropractic, P.c. | |
|
1519 S Reserve St, Missoula, MT 59801-4755 | |
| (406) 549-2006 | |
| (406) 549-6574 |
| Full Name | Matz Family Chiropractic, P.c. |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 1519 S Reserve St, Missoula, Montana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285957019 | NPI | - | NPPES |
| M000004192 | Other | MT | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 545 (Montana) | Primary |
| Provider Name | Steven S Matz |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1528117421 PECOS PAC ID: 4880685031 Enrollment ID: I20040518001330 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Dozens of child welfare experts will gather at the University of North Carolina at Chapel Hill Wednesday and Thursday (Feb. 22-23) for the first in a series of national meetings aimed at forging solutions to keep children safe and healthy.
A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).
KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.
A new study has been published in the journal Vaccines that summarizes the history of vaccines, reviews the current progress in COVID-19 vaccine technology, and discusses the status of intranasal COVID-19 vaccines as a potential pathway to immunization.
› Verified 2 days ago
| Provider Name | Linda M Matz |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1659402469 PECOS PAC ID: 4486645207 Enrollment ID: I20040520000958 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Dozens of child welfare experts will gather at the University of North Carolina at Chapel Hill Wednesday and Thursday (Feb. 22-23) for the first in a series of national meetings aimed at forging solutions to keep children safe and healthy.
A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).
KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.
A new study has been published in the journal Vaccines that summarizes the history of vaccines, reviews the current progress in COVID-19 vaccine technology, and discusses the status of intranasal COVID-19 vaccines as a potential pathway to immunization.
› Verified 2 days ago
| Provider Name | John J Matz |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1528053436 PECOS PAC ID: 4789783879 Enrollment ID: I20070702000277 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Dozens of child welfare experts will gather at the University of North Carolina at Chapel Hill Wednesday and Thursday (Feb. 22-23) for the first in a series of national meetings aimed at forging solutions to keep children safe and healthy.
A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).
KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.
A new study has been published in the journal Vaccines that summarizes the history of vaccines, reviews the current progress in COVID-19 vaccine technology, and discusses the status of intranasal COVID-19 vaccines as a potential pathway to immunization.
› Verified 2 days ago
| Provider Name | Brandon E Blank |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1174930275 PECOS PAC ID: 9931326139 Enrollment ID: I20140812001827 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Dozens of child welfare experts will gather at the University of North Carolina at Chapel Hill Wednesday and Thursday (Feb. 22-23) for the first in a series of national meetings aimed at forging solutions to keep children safe and healthy.
A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).
KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.
A new study has been published in the journal Vaccines that summarizes the history of vaccines, reviews the current progress in COVID-19 vaccine technology, and discusses the status of intranasal COVID-19 vaccines as a potential pathway to immunization.
› Verified 2 days ago
| Provider Name | Steven S Matz |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1952857625 PECOS PAC ID: 6901194968 Enrollment ID: I20161007001037 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Dozens of child welfare experts will gather at the University of North Carolina at Chapel Hill Wednesday and Thursday (Feb. 22-23) for the first in a series of national meetings aimed at forging solutions to keep children safe and healthy.
A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).
KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.
A new study has been published in the journal Vaccines that summarizes the history of vaccines, reviews the current progress in COVID-19 vaccine technology, and discusses the status of intranasal COVID-19 vaccines as a potential pathway to immunization.
› Verified 2 days ago
| Provider Name | Logan Michael Mikkelson |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1750814695 PECOS PAC ID: 6103185756 Enrollment ID: I20180105001241 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Dozens of child welfare experts will gather at the University of North Carolina at Chapel Hill Wednesday and Thursday (Feb. 22-23) for the first in a series of national meetings aimed at forging solutions to keep children safe and healthy.
A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).
KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.
A new study has been published in the journal Vaccines that summarizes the history of vaccines, reviews the current progress in COVID-19 vaccine technology, and discusses the status of intranasal COVID-19 vaccines as a potential pathway to immunization.
› Verified 2 days ago
| Provider Name | Austin J Goodell |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1700364767 PECOS PAC ID: 0648521583 Enrollment ID: I20180917000922 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Dozens of child welfare experts will gather at the University of North Carolina at Chapel Hill Wednesday and Thursday (Feb. 22-23) for the first in a series of national meetings aimed at forging solutions to keep children safe and healthy.
A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).
KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.
A new study has been published in the journal Vaccines that summarizes the history of vaccines, reviews the current progress in COVID-19 vaccine technology, and discusses the status of intranasal COVID-19 vaccines as a potential pathway to immunization.
› Verified 2 days ago
| Provider Name | Logan E Rossmiller |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1922665785 PECOS PAC ID: 4880928142 Enrollment ID: I20190620002434 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Dozens of child welfare experts will gather at the University of North Carolina at Chapel Hill Wednesday and Thursday (Feb. 22-23) for the first in a series of national meetings aimed at forging solutions to keep children safe and healthy.
A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).
KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.
A new study has been published in the journal Vaccines that summarizes the history of vaccines, reviews the current progress in COVID-19 vaccine technology, and discusses the status of intranasal COVID-19 vaccines as a potential pathway to immunization.
› Verified 2 days ago
| Provider Name | Cayden Napierala |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1245855030 PECOS PAC ID: 7214352897 Enrollment ID: I20200729002731 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Dozens of child welfare experts will gather at the University of North Carolina at Chapel Hill Wednesday and Thursday (Feb. 22-23) for the first in a series of national meetings aimed at forging solutions to keep children safe and healthy.
A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).
KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.
A new study has been published in the journal Vaccines that summarizes the history of vaccines, reviews the current progress in COVID-19 vaccine technology, and discusses the status of intranasal COVID-19 vaccines as a potential pathway to immunization.
› Verified 2 days ago
| Provider Name | Kelli Lynn Olson |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1669057899 PECOS PAC ID: 7113335043 Enrollment ID: I20210414001384 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Dozens of child welfare experts will gather at the University of North Carolina at Chapel Hill Wednesday and Thursday (Feb. 22-23) for the first in a series of national meetings aimed at forging solutions to keep children safe and healthy.
A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).
KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.
A new study has been published in the journal Vaccines that summarizes the history of vaccines, reviews the current progress in COVID-19 vaccine technology, and discusses the status of intranasal COVID-19 vaccines as a potential pathway to immunization.
› Verified 2 days ago
| Provider Name | Todd A Hubbard |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1992789952 PECOS PAC ID: 6507751443 Enrollment ID: I20210514002502 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Dozens of child welfare experts will gather at the University of North Carolina at Chapel Hill Wednesday and Thursday (Feb. 22-23) for the first in a series of national meetings aimed at forging solutions to keep children safe and healthy.
A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).
KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.
A new study has been published in the journal Vaccines that summarizes the history of vaccines, reviews the current progress in COVID-19 vaccine technology, and discusses the status of intranasal COVID-19 vaccines as a potential pathway to immunization.
› Verified 2 days ago
| Provider Name | Elizabeth E Grussling |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1689386898 PECOS PAC ID: 2062883341 Enrollment ID: I20230124002841 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Dozens of child welfare experts will gather at the University of North Carolina at Chapel Hill Wednesday and Thursday (Feb. 22-23) for the first in a series of national meetings aimed at forging solutions to keep children safe and healthy.
A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).
KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.
A new study has been published in the journal Vaccines that summarizes the history of vaccines, reviews the current progress in COVID-19 vaccine technology, and discusses the status of intranasal COVID-19 vaccines as a potential pathway to immunization.
› Verified 2 days ago
| Provider Name | Elizabeth Lee Roberts |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1669151213 PECOS PAC ID: 0547621716 Enrollment ID: I20230803003334 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Dozens of child welfare experts will gather at the University of North Carolina at Chapel Hill Wednesday and Thursday (Feb. 22-23) for the first in a series of national meetings aimed at forging solutions to keep children safe and healthy.
A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).
KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.
A new study has been published in the journal Vaccines that summarizes the history of vaccines, reviews the current progress in COVID-19 vaccine technology, and discusses the status of intranasal COVID-19 vaccines as a potential pathway to immunization.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matz Family Chiropractic, P.c. 1519 S Reserve St, Missoula, MT 59801-4755 Ph: (406) 549-2006 | Matz Family Chiropractic, P.c. 1519 S Reserve St, Missoula, MT 59801-4755 Ph: (406) 549-2006 |
News Archive
Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.
Dozens of child welfare experts will gather at the University of North Carolina at Chapel Hill Wednesday and Thursday (Feb. 22-23) for the first in a series of national meetings aimed at forging solutions to keep children safe and healthy.
A new register-based study from Karolinska Institutet in Sweden shows that drug therapy for ADHD does not entail an increased risk of suicide attempts or suicide, as was previously feared. The results are published in the British Medical Journal (BMJ).
KTH Royal Institute of Technology Stockholm and Biotechnology start-up BioSilta Oy of Oulu Finland have been collaborating over the last year to optimise protein screening in a range of microwell plate formats. The technique utilises EnBase Flo the newly developed Enzymatic Release media technology from BioSilta.
A new study has been published in the journal Vaccines that summarizes the history of vaccines, reviews the current progress in COVID-19 vaccine technology, and discusses the status of intranasal COVID-19 vaccines as a potential pathway to immunization.
› Verified 2 days ago
Clearwater Chiropractic Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 2330 South Higgins Ave, Suite 100, Missoula, MT 59801 Phone: 406-728-0330 Fax: 406-728-0330 | |
Dr. Thomas Raymond Taylor, Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 2126 Dixon Ave, Missoula, MT 59801 Phone: 406-541-2225 | |
Dr. Nicholas Smith, D.C Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2801 Great Northern Loop Ste 120, Missoula, MT 59808 Phone: 518-588-4369 | |
Mr. Christopher Lee Moore, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1802 Dearborn Ave, Suite 101, Missoula, MT 59801 Phone: 406-728-5114 Fax: 406-728-8121 | |
Dr. Morgan Viscio, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 2801 Great Northern Loop Ste 120, Missoula, MT 59808 Phone: 518-588-4369 | |
Dr. Troy Dion Doxey, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2330 S Higgins Ave Ste 100, Missoula, MT 59801 Phone: 406-728-0222 Fax: 406-728-0330 | |
Summit Chiropractic Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 1900 S Reserve St, Missoula, MT 59801 Phone: 406-549-0777 Fax: 406-721-9008 |